glp-1 and depression Frontiers GLP-1s may alleviate depression through

This underscores that these medications are chronic therapies similar to how antihypertensives or statins are long-term

Ultimately, the goal is not rapid or extreme weight loss but, rather, safe, sustainable, and medically meaningful improvements in health and quality of life

They may adjust your dosage or suggest an alternative medication

Semaglutide 2.4 mg weekly, assessed in 17,604 individuals with body mass index (BMI) 27 kg/m and cardiovascular disease (CVD), resulted in 8.51% weight loss at 104 weeks and a 20% reduction in nonfatal Myocardial Infarction (MI), stroke, and cardiovascular death

Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP: Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy